E&EATING & NUTRITION
Eating & Nutrition/August 24, 2026/3 min read

Managing Blood Sugar When Gastroparesis Slows Digestion

A new study brings together research and real-world experience to offer practical strategies for adjusting mealtime insulin when gastroparesis—a complication that slows stomach emptying—makes blood sugar management harder.

PubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

nutritiondietcarbohydratesglycemic

Key takeaways

  • Gastroparesis, which slows how food moves through the stomach, is a known complication of type 1 diabetes that makes blood sugar control more difficult.
  • There is limited research on how to adjust mealtime insulin doses for people with both type 1 diabetes and gastroparesis.
  • New expert recommendations suggest splitting insulin doses for people using injections or traditional pumps: taking part of the dose with the meal and the rest 2–4 hours later.
  • People using automated insulin delivery systems may benefit from taking smaller doses at mealtime and letting the system's algorithm manage blood sugar after eating.
  • The best approach varies from person to person based on symptoms, stomach function, and glucose patterns.

What Is Gastroparesis and Why Does It Matter for Type 1 Diabetes?

Gastroparesis is a condition in which the stomach empties more slowly than normal. For people with type 1 diabetes, this complication can make blood sugar management especially challenging because food enters the bloodstream at unpredictable times, making it harder to match insulin timing to carbohydrate intake.

While gastroparesis is recognized as a possible complication of diabetes, doctors have had few evidence-based strategies to guide insulin adjustments in this situation. A new mixed-methods study set out to fill this gap by combining published research with input from clinicians and people living with both conditions.

How Researchers Developed New Recommendations

The research team searched medical databases and found only seven studies directly relevant to insulin adjustment in type 1 diabetes with gastroparesis. They then surveyed 42 Canadian clinicians and 6 people with type 1 diabetes who have gastroparesis experience, using a structured expert panel process called the Delphi method. Recommendations required at least 80% agreement among panelists.

This combination of limited research plus expert and patient input helped the team propose practical strategies that go beyond what published studies alone could offer.

Insulin Adjustment Strategies for Injection and Pump Users

For people using insulin injections or traditional (non-automated) insulin pumps, the expert panel recommended splitting the mealtime insulin dose. This means taking 25–70% of the planned dose with the meal and administering the remaining portion 2–4 hours later, depending on individual needs and symptoms.

This approach allows insulin to be absorbed more gradually, reducing the mismatch between when insulin peaks and when food actually enters the bloodstream—a central problem when gastroparesis delays digestion.

A Different Approach for Automated Insulin Delivery Systems

For people using automated insulin delivery (AID) systems—also called artificial pancreas technology—the recommendations differ slightly. The panel suggested giving smaller insulin doses at mealtime and allowing the system's algorithm to manage post-meal blood sugar based on real-time glucose readings.

Because these systems continuously adjust insulin delivery, they may be better equipped to adapt to the variable and slower digestion that gastroparesis causes.

Why One-Size-Fits-All Doesn't Work

A key theme across both research and expert input was the importance of individualization. Symptoms, severity of delayed stomach emptying, and how quickly your glucose rises after eating all differ from person to person.

The study emphasizes that effective insulin adjustment for gastroparesis requires close monitoring of your own blood sugar patterns and working with your healthcare team to find what works best for your body. No single strategy suits everyone.

Evidence label

Source: Canadian journal of diabetes. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.